Lorcaserin Makes It Past Panel On The Strength Of Effect In Some Patients

The Endocrinologic and Metabolic Drugs Advisory Committee votes 18-4, with one abstention, in favor of lorcaserin for long-term treatment of overweight and obese individuals.